Previous 10 | Next 10 |
Aytu BioScience ( AYTU -2.9% ) has received over the preceding three weeks over $ 23M in cash proceeds from warrant exercises with prices ranging from $1.25 to $1.50. More news on: Aytu BioScience, Inc., Healthcare stocks news, Read more ...
3 Penny Stocks To Watch Before The Weekend While the markets continue to see increased volatility, penny stocks have seen interest building. If you think it’s just because of the cheap share price, you may be partially correct and here’s why. Many of the bigger names in industr...
Cash and Cash Equivalents of Approximately $62.5 on March 31, 2020 ENGLEWOOD, CO / ACCESSWIRE / April 7, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU) (the "Company"), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs announ...
100,000 COVID-19 Rapid Tests Ready to Ship Across the Country with 500,000 More on the Way ENGLEWOOD, CO / ACCESSWIRE / April 6, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), (the "Company"), a specialty pharmaceutical company focused on commercializing novel products that address signifi...
NEW YORK, April 03, 2020 (GLOBE NEWSWIRE) -- XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”), today provided an update on recent discussions with local airport authorities and healthcare partners so that it may begin providing screening and test...
Penny stocks are back in play this month in a big way. One of the biggest reasons why is that the entire market is experiencing massive volatility. In fact, if you look a little deeper, you’ll see that there have been many stocks that never before traded below $5 but are now considered ...
Forms New Business Unit XpresTest In Discussions for Initial Testing with Three Major Airports NEW YORK, April 03, 2020 (GLOBE NEWSWIRE) -- XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”), today provided an update on recent discussions with lo...
Aytu BioScience (NASDAQ: AYTU ) has begun shipping its rapid antibody blood test for COVID-19. Shares up 8% premarket. More news on: Aytu BioScience, Inc., Stryker Corporation, Novartis AG, Healthcare stocks news, Stocks on the move, Read more ...
First COVID-19 Rapid Tests Delivered to Denver First Responders ENGLEWOOD, CO / ACCESSWIRE / April 3, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), (the "Company"), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs announ...
Luckin Coffee (NASDAQ: LK ) -84% on fraud finding . More news on: Luckin Coffee Inc., Golar LNG Partners LP, Safe-T Group Ltd, Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Q2 2024 operating income of $2.4 million Q2 2024 net loss of $0.2 million and adjusted EBITDA 1 of $5.1 million Q2 2024 Rx Segment net revenue of $18.7 million, net income of $0.7 million, and adjusted EBITDA of $5.5 million Q2 2024 ADHD Portfolio net revenue up 49% compared to Q2...
Owens Corning Inc New (OC) is expected to report $2.82 for Q4 2023 Getty Realty Corporation (GTY) is expected to report $0.56 for Q4 2023 Bion Environmental Technologies Inc. (BNET) is expected to report for Q2 2024 Nexien BioPharma Inc (NXEN) is expected to report for Q2 2024 Ayt...
DENVER, CO / ACCESSWIRE / February 7, 2024 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, will report its financial and operational results for its second quarter of fiscal 2024 for the period ended December...